Trexquant Investment’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-40,542
Closed -$4.48M 1761
2025
Q1
$4.48M Sell
40,542
-15,644
-28% -$1.73M 0.05% 550
2024
Q4
$7.67M Sell
56,186
-43,163
-43% -$5.89M 0.09% 363
2024
Q3
$11.4M Buy
+99,349
New +$11.4M 0.14% 205
2024
Q2
Sell
-37,918
Closed -$5.23M 1744
2024
Q1
$5.23M Sell
37,918
-50,242
-57% -$6.93M 0.1% 285
2023
Q4
$11.6M Buy
88,160
+82,139
+1,364% +$10.8M 0.26% 82
2023
Q3
$677K Buy
+6,021
New +$677K 0.02% 893
2023
Q2
Sell
-58,769
Closed -$5.95M 1668
2023
Q1
$5.95M Buy
58,769
+3,022
+5% +$306K 0.16% 159
2022
Q4
$6.66M Buy
55,747
+49,911
+855% +$5.96M 0.19% 140
2022
Q3
$620K Buy
+5,836
New +$620K 0.02% 725
2022
Q1
Sell
-24,681
Closed -$2.1M 1608
2021
Q4
$2.1M Buy
+24,681
New +$2.1M 0.13% 200
2021
Q3
Sell
-8,294
Closed -$807K 1364
2021
Q2
$807K Buy
+8,294
New +$807K 0.07% 360
2021
Q1
Sell
-7,283
Closed -$698K 1347
2020
Q4
$698K Sell
7,283
-19,462
-73% -$1.87M 0.07% 351
2020
Q3
$2.57M Buy
+26,745
New +$2.57M 0.17% 168
2020
Q1
Sell
-50,763
Closed -$5.46M 1315
2019
Q4
$5.46M Buy
+50,763
New +$5.46M 0.32% 90
2019
Q3
Sell
-17,656
Closed -$1.49M 1028
2019
Q2
$1.49M Sell
17,656
-3,789
-18% -$320K 0.13% 229
2019
Q1
$1.89M Buy
+21,445
New +$1.89M 0.13% 226
2018
Q4
Sell
-16,980
Closed -$2.09M 1215
2018
Q3
$2.09M Buy
+16,980
New +$2.09M 0.16% 193
2018
Q2
Sell
-31,120
Closed -$2.58M 1098
2018
Q1
$2.58M Buy
31,120
+28,115
+936% +$2.33M 0.18% 170
2017
Q4
$233K Sell
3,005
-1,014
-25% -$78.6K 0.03% 862
2017
Q3
$246K Buy
+4,019
New +$246K 0.06% 538
2017
Q1
Sell
-40,116
Closed -$1.55M 1234
2016
Q4
$1.55M Buy
+40,116
New +$1.55M 0.25% 90
2016
Q1
Sell
-25,014
Closed -$1.42M 1083
2015
Q4
$1.42M Sell
25,014
-22,686
-48% -$1.28M 0.12% 269
2015
Q3
$1.9M Buy
47,700
+4,000
+9% +$159K 0.16% 171
2015
Q2
$2.09M Buy
+43,700
New +$2.09M 0.23% 77
2015
Q1
Sell
-25,622
Closed -$572K 1108
2014
Q4
$572K Buy
+25,622
New +$572K 0.1% 402